Archives

Chip Richter is the Vice President of Reimbursement at Artio Medical. He is a healthcare executive and leader with over two decades of experience in healthcare economics, reimbursement, health policy and government affairs.   Richter has a passion for translating national policy trends into practical go-to-market strategies and successfully achieving company reimbursement goals. He joins Artio from iCAD, where he established healthcare economics and reimbursement programs in preparation for the company’s

Emily Holliday is the Vice President of Human Resources at Artio Medical. She is a seasoned executive with over 20 years of Human Resources (HR) experience. Emily is a proactive and strategic leader with experience developing and implementing polices and processes that minimize risk and ensure a positive, diverse, and ethical workplace. She joined Artio from Trystar, where she led the HR team and managed talent acquisition, employee engagement, compensation

Joe Ingoglia is the Chief Commercial Officer at Artio Medical. He brings over 30 years of sales and marketing experience to Artio with success building and leading medical device commercial teams. Most recently, Joe served as the Vice President of US Sales for Medtronic’s $450M neurovascular business where he led the US neurovascular commercial team with responsibility for national accounts, sales operations, and field sales. Prior to Medtronic, Joe co-founded

Dan Tamez is the Senior Director of Nonclinical and Clinical Research. Dan brings over 25 years of deep domain experience in blood pumps and mechanical circulatory support, and is responsible for managing all nonclinical and clinical research programs at Artio Medical. Prior to joining Artio, Dan served as Distinguised Scientist at Medtronic plc, and was responsible for overseeing mechanical circulatory programs from design through nonclinical testing and clinical use. He

Irina Galkina is the Controller at Artio Medical. Prior to Artio, Irina was at Aratana Therapeutics, Inc. a publicly-traded animal health company, where she held roles of increasing responsibility in finance and accounting, from Accounting Manager to Controller. As Controller at Aratana, Irina was instrumental in the acquisition of Aratana by Elanco Animal Health, Inc. in 2019.  While at Elanco Irina focused on preparation for acquisition and subsequent integration of

Joe McConnell is the Vice President of Finance and Business Operations at Artio Medical. He brings over fifteen years of operations and finance experience to Artio. Serving as both Chief Operations Officer (COO) and Chief Financial Officer at several companies prior to Artio. Most recently, Joe was COO at Nolan Real Estate, a >$1B multifamily real estate investment firm, leading the company’s teams in operations, finance, asset management, marketing, human

Wendy Sawyer is the Senior Vice President of Operations and Quality at Artio Medical. Wendy brings more than 30 years of experience in operations, manufacturing, and product development in the medical device industry. For the last 10 years Wendy was Vice President of Operations at NeoTract, Inc. (aquired by Teleflex, Inc.) where she led all worldwide business unit activities related to Manufacturing, Manufacturing Engineering, Supply Chain and Logistics. She successfully scaled manufacturing and related activities

Mimi Fitterer is Senior Director of Technology at Artio Medical. Mimi has over 20 years of experience in medical device design, development, and process transfer. Mimi has experience leading product development efforts of new products at every stage from design concept through commercialization. Mimi was most recently at Intuitive Surgical, where she was responsible for exploring new areas for robotic surgical assistance in the endoluminal space. Prior to Intuitive Surgical,

Erdie De Peralta is Vice President of Clinical and Regulatory Affairs at Artio Medical. He is an experienced medical device professional with nearly 20 years of expertise in clinical and regulatory affairs, product development, and field and sales training. Previously, Erdie was the Vice President of Regulatory and Clinical Affairs at ExThera Medical Corporation, where he led the company in the development and execution of regulatory and clinical strategies, including

Delane Dale is Senior Director of Quality Assurance at Artio Medical. Delane has 30 plus years of medical device experience with various roles in quality assurance, quality engineering, and regulatory affairs. Delane was most recently with Confluent Medical Technologies where she was responsible for product development and sustaining quality engineering for the manufacture of neurovascular, endovascular, and cardiovascular products, including nitinol implants and catheter assemblies. Delane held similar roles with

Chris Parker is Senior Director of Marketing at Artio Medical. Chris is a dedicated leader in medical device, bringing nearly 30 years of marketing and sales expertise to the team. Chris comes to Artio from Abbott Vascular where he most recently served as Director of Marketing, leading a team responsible for global product launch initiatives across a broad portfolio of products. Prior to Abbott, Chris held marketing roles of increasing

John Ayres, JD, serves as Vice President of Corporate Development and General Counsel at Artio Medical. Prior to Artio, John was Vice President of Corporate Development and General Counsel at Aratana Therapeutics, Inc., a publicly-traded life science start-up company where he was instrumental in its merger with Elanco Animal Health, Inc. in 2019. Prior to Aratana, John was corporate and securities counsel at Amgen Inc., a global publicly-traded biotechnology company,

Paul Muller is Chief Technology Officer and General Manager at Artio Medical. He is an experienced leader with over 30 years of success developing cardiovascular, peripheral vascular, and neurovascular medical devices. Prior to Artio, Paul was Chief Technology Officer and General Manager at Flow Forward Medical (acquired by Artio) where he led the product development team and moved the Arteriovenous Fistula Eligibility System program to clinical readiness. Prior to Flow

Scott Richardson is Director of Creative Device Design at Artio where he has played a key role in the growth of Artio’s product portfolio and intellectual property estate. Scott has over 30 years of cardiovascular medical device engineering experience, including at Thermo Cardiosystems, Thoratec, Levitronix, and Flow Forward Medical. He enjoys using his broad and deep technical expertise and inventive nature to find novel, practical solutions to difficult medical device

William Whitaker is a co-founder of Artio Medical and previously co-founded Flow Forward Medical, Novita Therapeutics, and Proteon Therapeutics (PRTO) where he served as Vice President, General Counsel, and Director. He helped raise more than $120 million in capital and grants for the various companies. Prior to this, Whitaker was a Partner at two law firms before forming his own practice. He had a diverse career practicing in such areas

Dr. Blaise Baxter is a Neuro and Peripheral Interventional Radiologist. He recently served as Chief/Chair of the Radiology Department at Erlanger Health System. Dr. Baxter is currently a Special Government Employee for the Neurological Devices Panel for the FDA Medical Devices Advisory Committee. In addition, Dr. Baxter is the immediate Past-President of the Society of NeuroInterventional Surgery (SNIS). He is also an Executive Committee Member of American Society of NeuroRadiology

Nicholas Franano, MD, is a physician, scientist, inventor, and entrepreneur. He is President and CEO of Artio Medical, and a co-founder. Dr. Franano is an experienced entrepreneur, founding several companies including Artio Medical, Flow Forward Medical, Novita Therapeutics, and Proteon Therapeutics (NYSE: PRTO). Dr. Franano has held positions of President, CEO, and CSO at these companies, which have raised collectively over $120 million in capital and grants. Before Proteon, Dr.

Jennifer Martin is Director of Marketing and Operations at Artio Medical. Jennifer is an experienced marketing professional in neurovascular market. Previously, Jennifer was a Global Product Manager at Stryker Neurovascular where she commercialized and managed several products for the treatment of hemorrhagic and ischemic stroke. She was also a Business Development consultant for a promising start-up addressing Alzheimer’s disease. Jennifer received a Bachelor of Arts in Neurobiology from Harvard University.

Ryan Moore is Senior Program Director at Artio. Ryan joins the team with over 15 years of medical device experience in various roles including R&D, Clinical Sciences, and Program Management. Most recently Ryan was with Confluent Medical where he led the implementation of their project management system and also managed several Product Development programs from concept feasibility to high-volume production. Prior to this, he was a Senior R&D Engineer and

Vera Shinsky is the Senior Director of Technology at Artio Medical. She brings extensive medical device engineering experience to the team from a career focused in the neurovascular space. Prior to joining Artio, Vera was Director of Technology at Route 92 Medical/Highway 1 Medical, leading and participating in all aspects of product development. Prior to Route 92, she was Project Manager at Medina Medical and instrumental in the integrating and